Chargement en cours...
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1985
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180335/ https://ncbi.nlm.nih.gov/pubmed/3002246 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|